Table 1.

Demographic and ocular characteristics of the included glaucomatous eyes.

	Without ADRVD	With ADRVD	P
Participants, n	18	9
Age, mean (SD), years	65.5 (13.5)	58.7 (12.8)	0.220*
Female, n (%)	10 (55.6)	4 (44.4)	0.586**
Eyes, n	21	13
Age, mean ± SD, years	65.8 (13.0)	60.4 (12.5)	0.242*
Female, n (%)	13 (61.9)	6 (46.2)	0.369**
Ocular characteristics
LogMAR BCVA, mean (SD)	0.00 (0.12)	0.01 (0.10)	0.662*
SE, mean (SD), dioptres	−1.7 (5.0)	−4.1 (2.7)	0.124*
IOP, mean (SD), mmHg	16.0 (9.9)	13.2 (3.8)	0.342*
Axial length, mean (SD), mm	25.1 (1.3)	25.7 (1.7)	0.232*
RNFL thickness, mean (SD), µm	61.5 (19.7)	61.5 (19.7)	0.689*
mGCL thickness, mean (SD), µm	19.4 (2.7)	19.0 (2.9)	0.668*
PSD, mean (SD), dB	9.1 (4.7)	11.7 (3.0)	0.086*
MD, mean (SD), dB	−9.3 (6.8)	−12.4 (5.6)	0.177*
Systemic characteristics
History of hypertension, n (%)	7 (33.3)	7 (53.9)	0.238**
History of diabetes, n (%)	4 (19.1)	0 (0.0)	0.041**

ADRVD, vertical asymmetrical deep retinal vessel density reduction; VF, visual field; SD, standard deviation; logMAR, logarithm of the minimum angle of resolution; BCVA, best-corrected visual acuity; SE, spherical equivalent; IOP, intraocular pressure; PSD, pattern standard deviation; MD, mean deviation; RNFL, retinal nerve fibre layer; mGCL, macular ganglion cell layer.

*P value based on unpaired t-tests. **P value based on chi-square tests.